Description
Vudalimab Biosimilar - Anti-CTLA4/PDCD1 mAb - Research Grade
Target
CTLA4/PDCD1
Target Alias Name
Vudalimab/ANTI-PD-1/ANTI-CTLA-4 XMAB20717/ IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3/ ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4/ CD152)) AND ANTI-(HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1/ PD-1/ PD1/ CD279))/ MONOCLONAL ANTIBODY/ BISPECIFIC/CTLA4/PDCD1/anti-CTLA4/PDCD1
Isotype/Mimetic
Bispecific /IgG1/Kappa/Kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression